Vimarsana
Biggest News Aggregation in the World

Page 11 - Seth Lederman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Seth Lederman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Seth Lederman Today - Breaking & Trending Today

Cyclobenzaprine reduces pain, improves sleep quality in patients with fibromyalgia - Vimarsana News

Cyclobenzaprine reduces pain, improves sleep quality in patients with fibromyalgia

Patients with fibromyalgia who receive a sublingual tablet form cyclobenzaprine experience reduced daily pain, and improved sleep quality, compared with those who received placebo, according to a press release from the drug’s manufacturer.

Source: healio.com
Tonix Pharmaceuticals TNX-1500 monoclonal antibody published in American Journal of Transplantation - Vimarsana News

Tonix Pharmaceuticals TNX-1500 monoclonal antibody published in American Journal of Transplantation

Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Seth Lederman joins Natalie Stoberman from the Proactive studios to share the findings of two publications in the...

The NIH poured $1 billion into long Covid research, with little to show for it - Vimarsana News

The NIH poured $1 billion into long Covid research, with little to show for it

A STAT and MuckRock investigation shows the NIH hasn’t picked up the pace on its long Covid research. Instead, the delays have compounded.

MD representatives introduce bills to address education inequities, boost federal funding - Vimarsana News

MD representatives introduce bills to address education inequities, boost federal funding

Maryland Democrats have proposed legislation aimed at addressing educational inequities and eliminating academic achievement gaps.

Tonix signs agreement with UMB to use monoclonal antibodies in preventing heart transplant rejection - Vimarsana News

Tonix signs agreement with UMB to use monoclonal antibodies in preventing heart transplant rejection

Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Seth Lederman joins Natalie Stoberman from the Proactive newsroom to share its new research agreement with...